FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to a novel crystalline form of threo glycopirronium chloride, method of obtaining thereof and application for pharmaceutical purposes.
EFFECT: obtaining the novel crystalline form of threo glycopyrronium chloride.
8 cl, 4 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AEROSOL FORMULATION FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2010 |
|
RU2567040C2 |
| COMBINATION OF COMPOUNDS, WHICH CAN BE APPLIED IN TREATMENT OF RESPIRATORY DISEASES, ESPECIALLY CHRONICAL OBSTRUCTIVE LUNG DISEASE (COLD) AND ASTHMA | 2006 |
|
RU2414222C2 |
| OBTAINING MICRONIZED GLYCOPYRRONIUM SALT PARTICLES BY HYDRODYNAMIC CAVITATION | 2017 |
|
RU2723549C2 |
| PARTICLE SIZE REDUCTION OF ANTIMUSCARINIC COMPOUND | 2014 |
|
RU2667636C2 |
| ORGANIC COMPOUNDS | 2004 |
|
RU2382783C2 |
| COMBINATION TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2010 |
|
RU2561052C2 |
| TOSYLATE SALT OF 5-PYRAZOLYL-2-PYRIDONE DERIVATIVE EFFECTIVE IN COPD TREATMENT | 2010 |
|
RU2526038C2 |
| SOLID FORMS OF N-(7-AZABICYCLO[2,2,1]HEPTAN-7-YL-)-2-(TRIFLUOROMETHYL)PHENYL)-4-OXO-5-(TRIFLUOROMETHYL)-1,4-DIHYDROQUIINOLINE-3-CARBOXAMIDE | 2009 |
|
RU2518479C2 |
| AMINE DERIVATIVES AND USE THEREOF IN BETA-2-ADRENORECEPTOR MEDIATED DISEASES | 2007 |
|
RU2472783C2 |
| POLYMORPHIC FORM | 2009 |
|
RU2448966C1 |
